HIV Surveillance Summary Georgia, 2020 HIV/AIDS Epidemiology Section Epidemiology Program Division of Health Protection Georgia Department of Public Health 2020 Georgia HIV Surveillance Summary Page 1 The HIV Surveillance Summary, Georgia 2020 is published by the Georgia Department of Public Health (DPH), HIV/AIDS Epidemiology Section (HAES), 2 Peachtree Street NW, Atlanta, Georgia 30303. Data are presented from known diagnoses and laboratory reports entered into the Georgia Enhanced HIV/AIDS Reporting System (eHARS). All data are provisional. The HIV Surveillance Summary, Georgia 2020 is not copyrighted and may be used and reproduced without permission. Citation of the source is, however, appreciated. SUGGESTED CITATION: Georgia Department of Public Health, HIV/AIDS Epidemiology Section HIV Surveillance Summary, Georgia 2020, https://dph.georgia.gov/data-fact-sheet-summaries, Published April 2022, [Accessed: date] ACKNOWLEDGEMENTS: Publication of this report was made possible with the contributions of the Georgia DPH HAES Core HIV Surveillance staff, HIV Case Report Forms submitted by Georgia healthcare facility staff, HIV infection related laboratory test results transmitted by laboratory facilities in Georgia, data matches with other DPH programs, and the ongoing efforts of multiple individuals from public and private sector organizations dedicated to improving surveillance, prevention, testing, and care of persons living with HIV infection. Georgia HIV Core Surveillance Team contributors: Jose Adame, Lauren Barrineau-Vejjajiva, Thelma Fannin, Latosha Johnson, Rodriques Lambert, Daniel Mauck, Mildred McGainey, Contessa Meadows, Latoya Moss, Kim Norris, Rama Namballa, Doris Pearson, A. Eugene Pennisi, Sylve Rawls, Akilah Spratling, and Gerriana Willams. This report was prepared by the following staff from the Georgia Department of Public Health: Nellie Garlow, MPH, Pascale Wortley, MD, MPH; Cherie Drenzek, DVM, MS. 2020 Georgia HIV Surveillance Summary Page 2 Table of Contents INTRODUCTION ....................................................................................................................................................................... 5 TECHNICAL NOTES .................................................................................................................................................................. 6 Definitions ........................................................................................................................................................................... 6 References .......................................................................................................................................................................... 8 TABLES................................................................................................................................................................................... 10 HIV Diagnoses and persons living with HIV, Georgia, 2020 .............................................................................................. 11 Table 1. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses, Georgia, 2020 ................................................ 11 Table 2. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among males, Georgia, 2020.......................... 12 Table 3. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among females, Georgia, 2020 ...................... 13 Table 4. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among transgender persons, Georgia, 2020.. 14 Table 5. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), Georgia, as of 12/31/2020 ....................... 15 Table 6. Persons living with HIV (PLWH), and PLWH ever stage 3 (AIDS), males, Georgia, as of 12/31/2020 ............. 16 Table 7. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), females, Georgia, as of 12/31/2020......... 17 Table 8. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), transgender persons, Georgia, as of 12/31/2020 ................................................................................................................................................................... 18 HIV Diagnoses and Persons Living with HIV by Public Health District .............................................................................. 19 Table 9. HIV Diagnoses and Persons Living with HIV, District 1-1 (Rome), Georgia, 2020 ........................................... 19 Table 10. HIV Diagnoses and Persons Living with HIV, District 1-2 (Dalton), Georgia, 2020........................................ 20 Table 11. HIV Diagnoses and Persons Living with HIV, District 2 (Gainesville), Georgia, 2020 .................................... 21 Table 12 HIV Diagnoses and Persons Living with HIV, District 3-1 (Cobb-Douglas), Georgia, 2020 ............................. 22 Table 13. HIV Diagnoses and Persons Living with HIV, District 3-2 (Fulton), Georgia, 2020 ........................................ 23 Table 14. HIV Diagnoses and Persons Living with HIV, District 3-3 (Clayton), Georgia, 2020 ...................................... 24 Table 15. HIV Diagnoses and Persons Living with HIV, District 3-4 (East Metro), Georgia, 2020................................. 25 Table 16. HIV Diagnoses and Persons Living with HIV, District 3-5 (DeKalb), Georgia, 2020 ..................................... 266 Table 17. HIV Diagnoses and Persons Living with HIV, District 4 (LaGrange), Georgia, 2020....................................... 27 Table 18. HIV Diagnoses and Persons Living with HIV, District 5-1 (Dublin), Georgia, 2020 ........................................ 28 Table 19. HIV Diagnoses and Persons Living with HIV, District 5-2 (Macon), Georgia, 2020 ....................................... 29 Table 20. HIV Diagnoses and Persons Living with HIV, District 6 (Augusta), Georgia, 2020......................................... 30 Table 21. HIV Diagnoses and Persons Living with HIV, District 7 Columbus), Georgia, 2020 ....................................... 31 Table 22. HIV Diagnoses and Persons Living with HIV, District 8-1 (Valdosta), Georgia, 2020..................................... 32 Table 23. HIV Diagnoses and Persons Living with HIV, District 8-2 (Albany), Georgia, 2020........................................ 33 Table 24. HIV Diagnoses and Persons Living with HIV, District 9-1 (Savannah), Georgia, 2020 ................................... 34 Table 25. HIV Diagnoses and Persons Living with HIV, District 9-2 (Waycross), Georgia, 2020 ................................... 35 2020 Georgia HIV Surveillance Summary Page 3 Table 26. HIV Diagnoses and Persons Living with HIV, District 10 (Athens), Georgia, 2020 ........................................ 36 HIV Diagnoses and Persons Living with HIV, Atlanta MSA................................................................................................ 37 Table 27. HIV Diagnoses and Persons Living with HIV, Atlanta Metropolitan Statistical Area1, Georgia, 2020 ........... 37 Late Diagnoses by Public Health District and Atlanta MSA .............................................................................................. 38 Table 28. Late diagnoses by Public Health District and for Atlanta Metropolitan Statistical Area, Georgia, 2020 ...... 38 Public Health District and County Rates ........................................................................................................................... 39 Table 29. HIV diagnoses and persons living with HIV (PLWH): Public Health District and County number and rates per 100,000 population, Georgia 2020 ......................................................................................................................... 39 Distribution of General Population by Race/Ethnicity...................................................................................................... 43 Table 30. Distribution of the general population by race/ethnicity, Georgia 2020...................................................... 43 HIV/AIDS RESOURCES: .......................................................................................................................................................... 44 2020 Georgia HIV Surveillance Summary Page 4 INTRODUCTION HIV infection remains an important public health problem in the state of Georgia. As of the end of 2020, there were 60,073 persons living with HIV in Georgia, and 2,018 persons were diagnosed in 2020. The number of persons living with HIV continues to increase, because of effective therapies now available. Based on the Centers for Disease Control and Prevention's 2019 HIV Surveillance Report, Georgia was ranked the fourth highest in the nation for both the total number of new diagnoses of HIV infection among adults and adolescents after Florida, California, and Texas, and ranked the fifth highest for the number of persons living with HIV infection, after Florida, California, Texas, and New York1. Georgia ranked 2nd in the rate of HIV diagnosis among adults and adolescents, and 4th in the rate of persons living with HIV. Monitoring the HIV/AIDS epidemic and understanding the burden of HIV infection in Georgia are essential for meeting the goals stated in the 2022-2025 National HIV/AIDS Strategy to: 1) prevent new HIV infections; 2) improve HIV-related health outcomes for persons living with HIV; 3) reduce HIV-related health disparities and inequities, and 4) achieve a more coordinated national response to the HIV epidemic among all partners and stakeholders.2 Information on the Georgia HIV care continuum can be found in a separate report at the following web page: https://dph.georgia.gov/hiv-care-continuum. Interpreting HIV Surveillance Data During the COVID-19 Pandemic After the COVID-19 pandemic was declared a national and state emergency in March 2020, access to healthcare services, including HIV testing, prevention, and care-related services, became reduced or temporarily suspended. Therefore, decreases seen in 2020 HIV diagnoses may partly represent decreased availability of HIV testing or delays in seeking HIV testing. As a result, 2020 HIV surveillance data should be interpreted with caution. 2020 Georgia HIV Surveillance Summary Page 5 TECHNICAL NOTES Georgia statutes and regulations (O.C.G.A. 3112-2(b)) require healthcare providers (such as nurses, nurse practitioners, doctors, physician assistants) licensed in the state of Georgia to report all cases of HIV infection and/or Stage 3 (AIDS) to the Georgia DPH within seven days of diagnosis3. Laboratories licensed in the state of Georgia are required to report all HIV-related laboratory test results within 7 days. The information is used to monitor the HIV/AIDS epidemic in Georgia and guide program planning and evaluation. The data presented in the accompanying tables are based on confidential case reports collected through the Georgia DPH enhanced HIV/AIDS Reporting System (eHARS). AIDS reporting began in the early 1980s, and HIV reporting began in Georgia on December 31, 2003. Electronic transmission of laboratory test results began in 2011. Receipt of CD4 counts and viral load tests make it possible to estimate the HIV Care Continuum for persons with a diagnosis of HIV infection in the state of Georgia (reports are available at: https://dph.georgia.gov/hiv-carecontinuum). This report includes surveillance data reported through December 31, 2021 for cases diagnosed through December 31, 2020. This report is limited to cases diagnosed through December 2020 to take into account delays in reporting, and to allow for obtaining follow up information on reported cases. 2020 Georgia HIV Surveillance Summary HIV diagnoses include persons with a diagnosis of HIV infection, regardless of the stage of disease at diagnosis, who were residents of Georgia at the time of diagnosis. Persons living with HIV are those with a residence in the state of Georgia, based on current information available in the Georgia HIV/AIDS surveillance system, regardless of where they resided at the time of diagnosis. Persons residing in correctional facilities are included in this report and may inflate rates in certain geographic regions where there are large numbers of HIV-positive inmates. Information on transmission category is missing for one quarter of cases. Multiple imputation, a statistical approach, is used to replace each missing transmission category with a set of plausible values that represent the uncertainty about the true, but missing, value4. The methods were applied to adult and adolescent, but not pediatric cases. Multiple imputation is considered by the Centers for Disease Control and Prevention to be the best method for redistribution of missing data in large databases. Transmission category is shown with missing data, and after multiple imputation. Cases missing race/ethnicity are not assigned a risk through multiple imputation. Persons for whom the current identity box "transgender" was checked on the case report form are classified as transgender. Because providers often do not complete all case report form fields, the numbers Page 6 reported here are most likely an underestimate. Additionally, because the current identity fields were added to the case report form in 2007, prevalent counts of HIV among transgender persons may be incomplete. Persons with transmission category "perinatal/other pediatric" include infants born in Georgia who acquired HIV through perinatal transmission, as well as infants born outside of Georgia who acquired HIV through perinatal transmission and were first diagnosed with HIV in Georgia. For more information on perinatal HIV exposure surveillance in Georgia, see the Perinatal HIV Exposure Surveillance Report at https://dph.georgia.gov/epidemiology/georgias-hivaidsepidemiology-section/georgia-hiv-surveillance-data. For data presented at the Public Health District or MSA level, all cells with values between 1 and 4 observations are censored in accordance with the Georgia Department of Public Health HIV Surveillance Security and Confidentiality Guidelines. Definitions HIV DIAGNOSES are cases diagnosed between January 1 and December 31, 2020, with an address at the time of HIV diagnosis was in Georgia, and who were reported to the Georgia Department of Public Health by December 31, 2020, regardless of stage at diagnosis. This group includes persons whose initial diagnosis is Stage 3 (AIDS). LATE DIAGNOSES are the subset of HIV diagnoses who 2020 Georgia HIV Surveillance Summary are found to be Stage 3 (AIDS) within 12 months of HIV diagnosis date. Such persons are termed late diagnoses because their advanced stage at diagnosis indicates that they were most likely infected for many years before diagnosis. STAGE 3 (AIDS) DIAGNOSES include two groups: 1) persons newly diagnosed with HIV in 2020, found to meet the definition for Stage 3 (AIDS) at diagnosis, and with an address at or near the time of Stage 3 diagnosis in Georgia; and, 2) persons found to meet the Stage 3 definition in 2020 with an address at or near the time of Stage 3 diagnosis in Georgia, regardless of the date of their initial HIV diagnosis. PERSONS LIVING WITH HIV INFECTION are persons diagnosed by December 31, 2020, who are not known to be deceased, and for whom the most recent address available is in Georgia. PERSONS LIVING WITH HIV, EVER STAGE 3 are persons diagnosed by December 31, 2020, who are not known to be deceased, for whom the most recent address available is in Georgia, and who met the case definition for Stage 3 (AIDS) at some point. TRANSMISSION CATEGORIES presented in this report follow the standards created by the Centers for Disease Control and Prevention (CDC) and have been used for many years. According to the CDC, transmission category is the term for the classification of cases that summarizes a person's possible HIV risk factors. The summary classification results from selecting the one most likely risk factor to have been responsible for HIV Page 7 transmission from the presumed hierarchical order of probability. For surveillance purposes, HIV and AIDS cases are counted only once in the hierarchy of transmission categories. Persons with more than one reported risk factor for HIV infection are classified in the transmission category according to the behavior that is most likely to have resulted in transmission. The exception is men who report sexual contact with other men and injection drug use; this group makes up a separate transmission category. Persons whose transmission category is classified as heterosexual contact are persons who report heterosexual contact specifically with a person known to have or be at high risk for HIV infection (e.g., an injection drug user/IDU). The term high risk is not included in the transmission category label for heterosexual contact in the tables because heterosexual contact itself is the risk factor most likely to have been responsible for transmission. However, the Table 3 footnote regarding this category clarifies how the data are defined: "heterosexual contact with a person known to have, or to be at high risk for, HIV infection". CURRENT RESIDENCE Current address is determined using the date of the most recently-entered residential address as of 12/31/2020 into the Georgia eHARS. The number of persons living with HIV is based on current address. VITAL STATUS: Persons are assumed to be alive unless otherwise documented or reported. The Georgia DPH performs an annual match of the eHARS database with the Georgia Vital Records death data, the National Death Index and the Social Security Death Index to ascertain vital status. 2020 Georgia HIV Surveillance Summary RATES: Denominators for population rates are based on the 2020 estimates of the Georgia resident population retrieved from the Georgia Department of Public Health, Office of Health Indicators for Planning (OHIP). Rates are per 100,000 population. Rates are not presented for case numbers less than 12 because these rates have relative standard errors greater than 30% and are considered unreliable. PERCENTAGES: Total percentages may not add up to 100% due to rounding. COUNTS: Counts in the gender, race/ethnicity, and age categories may not add up to the overall totals due to a small number of cases with missing information (<2 percent). References 1. Centers for Disease Control and Prevention. HIV Surveillance Report, 2019; vol.32. http://www.cdc.gov/hiv/library/reports/hivsurveillance.html. Published May 2021. 2. White House Office of National AIDS Policy. National HIV/AIDS Strategy (2022-2025). https://hivgov-prodv3.s3.amazonaws.com/s3fs-public/NHAS-20222025.pdf. Published 2021. 3. Department of Public Health, Rules and regulations 290-48.11 (2003); Official Code of Georgia Annotated (O.C.G.A.) 31-22-9.2 (2011) Page 8 4. Harrison KM, Kajese T, Hall HI, Song R. Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach. Public Health Rep 2008;123:61827. 2020 Georgia HIV Surveillance Summary Page 9 TABLES 2020 Georgia HIV Surveillance Summary Page 10 HIV Diagnoses and persons living with HIV, Georgia, 2020 Table 1. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses, Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing HIV Diagnoses (all stages) Total N %* 2,016 100 Gender Identity Cisgender Male 1,548 76.7 Cisgender Female 409 20.3 Transgender Persons 59 2.9 Race/Ethnicity Black/Non Hispanic 1,457 72.2 White/Non Hispanic 321 15.9 Hispanic/Latino, Any Race 177 8.8 American Indian/Alaska Native 2 0.1 Asian/Native Hawaiian/Pacific Islander 17 0.8 Multiple races 20 1.0 Age Group at Diagnosis (Years) <13 2 0.1 13-19 100 5.0 20-29 815 40.4 30-39 561 27.8 40-49 257 12.7 50-59 204 10.1 60+ 79 3.9 Transmission Category (Unadjusted) Male-to-male sexual contact 1,126 55.8 Injection drug use 35 1.7 Male-to-male sexual contact and injection drug use 27 1.3 Heterosexual contact3 364 18.0 Perinatal/other pediatric4 0 0.0 Unknown 466 23.1 Transmission Category (Adjusted)5 Male-to-male sexual contact 1,356 67.2 Injection drug use 64 3.2 Male-to-male sexual contact and injection drug use 35 1.7 Heterosexual contact3 539 26.7 Perinatal/other pediatric4 0 0.0 Late HIV Diagnoses1 N %* 460 100 row % 22.8 Stage 3 (AIDS) Diagnoses2 N %* 1,088 100 342 74.3 22.1 821 75.4 103 22.4 25.2 235 21.6 15 3.3 25.4 32 2.9 325 70.7 22.3 799 73.4 73 15.9 22.7 158 14.5 46 10.0 26.0 91 8.4 1 0.2 50.0 1 0.1 9 2.0 52.9 14 1.3 1 0.2 5.0 19 1.7 0 0.0 0.0 0 0.0 9 2.0 9.0 11 1.0 134 29.1 16.4 257 23.6 128 27.8 22.8 321 29.5 93 20.2 36.2 229 21.0 69 15.0 33.8 179 16.4 27 5.9 34.2 92 8.4 222 48.3 19.7 539 49.5 4 0.9 11.4 32 2.9 4 0.9 14.8 24 2.2 108 23.5 29.7 224 20.6 0 0.0 1 0.1 122 26.5 26.2 268 24.6 280 60.8 20.6 668 61.3 13 2.8 20.3 50 4.6 6 1.3 17.1 30 2.8 156 34.0 28.9 329 30.2 0 0.0 1 0.1 *Percentages may not add up to 100% due to rounding. 1. Late diagnosis: stage 3 (AIDS) diagnosis within 12 months of HIV diagnosis. Row % is percent of HIV diagnoses that were late diagnoses 2. Stage 3 (AIDS): includes persons diagnosed with stage 3 in 2020, regardless of year of HIV diagnosis. 3. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with. hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 4. Perinatal/other pediatric: cases <13 born to HIV-infected mother, cases <13 with missing risk, and cases <13 with other risk (e.g. sexual transmission). 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding. 2020 Georgia HIV Surveillance Summary Page 11 Table 2. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among Cis-Gender Males, Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing Total Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group at Diagnosis (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact3 Perinatal/other pediatric4 Unknown Transmission Category (Adjusted)5 Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact3 Perinatal/other pediatric4 HIV Diagnoses (all stages) N 1,546 %* 100.0 1,103 71.3 240 15.5 153 9.9 2 0.1 11 0.7 17 1.1 1 0.1 75 4.8 675 43.6 448 28.9 164 10.6 139 9.0 46 3.0 1,069 69.1 21 1.4 26 1.7 125 8.1 0 0.0 307 19.8 1,299 83.9 33 2.1 34 2.2 161 10.4 0 0.0 Late HIV Diagnoses1 Stage 3 (AIDS) Diagnoses2 N %* row % 342 100.0 22.1 N %* 821 100.0 240 70.2 50 14.6 40 11.7 1 0.3 5 1.5 1 0.3 21.8 595 72.5 20.8 120 14.6 26.1 74 9.0 50.0 1 0.1 45.5 10 1.2 5.9 15 1.8 0 0.0 8 2.3 112 32.7 101 29.5 61 17.8 48 14.0 12 3.5 0.0 0 0.0 10.7 9 1.1 16.6 212 25.8 22.5 260 31.7 37.2 151 18.4 34.5 126 15.3 26.1 63 7.7 207 60.5 2 0.6 4 1.2 48 14.0 0 0.0 81 23.7 19.4 508 61.9 9.5 21 2.6 15.4 23 2.8 38.4 90 11.0 0 0.0 26.4 178 21.7 265 77.4 6 1.7 6 1.8 60 17.6 0 0.0 20.4 637 77.6 18.2 29 3.6 17.6 29 3.6 37.3 117 14.2 0 0.0 * Percentages may not add up to 100% due to rounding. 1. Late diagnosis: stage 3 (AIDS) diagnosis within 12 months of HIV diagnosis. Row % is percent of HIV diagnoses that were late diagnoses 2. Stage 3 (AIDS): includes persons diagnosed with stage 3 in 2020, regardless of year of HIV diagnosis. 3. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with. hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 4. Perinatal/other pediatric: cases born to HIV-infected mother, cases <13 with missing risk, and cases <13 with other risk (e.g. sexual transmission). 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding. 2020 Georgia HIV Surveillance Summary Page 12 Table 3. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among Cis-Gender Females, Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing Total Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group at Diagnosis (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Injection drug use Heterosexual contact3 Perinatal/other pediatric4 Unknown Transmission Category (Adjusted)5 Injection drug use Heterosexual contact3 Perinatal/other pediatric4 HIV Diagnoses (all stages) N %* 407 100.0 Late HIV Diagnoses1 N %* row % 103 100.0 25.3 Stage 3 (AIDS) Diagnoses2 N %* 234 100.0 308 75.3 75 72.8 24.4 180 76.6 71 17.4 20 19.4 28.2 34 14.5 19 4.6 4 3.9 21.1 12 5.1 0 0.0 0 0.0 0 0.0 6 1.5 4 3.9 66.7 4 1.7 3 0.7 0 0.0 0.0 4 1.7 1 0.2 0 0.0 0.0 22 5.4 0 0.0 0.0 104 25.4 15 14.6 14.4 96 23.5 21 20.4 21.9 88 21.5 31 30.1 35.2 65 15.9 21 20.4 32.3 33 8.1 15 14.6 45.5 0 0.0 1 0.4 29 12.3 51 21.7 74 31.5 51 21.7 29 12.3 14 3.4 2 1.9 14.3 11 4.7 238 58.2 60 58.3 25.2 134 57.0 0 0.0 0 0.0 1 0.4 157 38.4 41 39.8 26.1 89 37.9 31 7.5 7 6.6 22.6 21 8.9 375 91.8 96 93.4 25.6 212 90.3 0 0.0 0 0.0 1 0.4 * Percentages may not add up to 100% due to rounding. 1. Late diagnosis: stage 3 (AIDS) diagnosis within 12 months of HIV diagnosis. Row % is percent of HIV diagnoses that were late diagnoses 2. Stage 3 (AIDS): includes persons diagnosed with stage 3 in 2020, regardless of year of HIV diagnosis. 3. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with. hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 4. Perinatal/other pediatric: cases born to HIV-infected mother, cases <13 with missing risk, and cases <13 with other risk (e.g. sexual transmission). 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding. 2020 Georgia HIV Surveillance Summary Page 13 Table 4. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among Transgender Persons, Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing HIV Diagnoses (all stages) Late HIV Diagnoses1 Stage 3 (AIDS) Diagnoses2 Total N %* 59 100.0 N %* 15 100.0 row % 25.4 N %* 32 100.0 Gender Identity Transgender Woman Transgender Man Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group at Diagnosis (Years) 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Sexual contact3 Sexual contact and injection drug use Unknown Transmission Category (Adjusted)4 Sexual contact3 Sexual contact and injection drug use Injection drug use 57 96.6 15 100.0 26.3 2 3.4 0 0.0 0.0 45 76.3 10 66.7 22.2 9 15.3 3 20.0 33.3 5 8.5 2 13.3 40.0 0 0.0 0 0.0 -- 0 0.0 0 0.0 -- 0 0.0 0 0.0 -- 2 3.4 1 6.7 50.0 35 59.3 7 46.7 20.0 17 28.8 6 40.0 35.3 5 8.5 1 6.7 20.0 0 0.0 0 0.0 0 0.0 0 0.0 57 96.5 15 100.0 26.3 1 1.7 0 0.0 0.0 1 1.7 0 0.0 0.0 28 98.3 15 100.0 1 1.7 0 0.0 0 0.0 0 0.0 0.0 32 100.0 0 0.0 24 75.0 4 12.5 4 12.5 0 0.0 0 0.0 0 0.0 1 3.1 15 46.9 10 31.3 4 12.5 2 6.3 0 0.0 31 96.9 1 3.1 0 0.0 31 96.9 1 3.1 0 0.0 1. Late diagnosis: stage 3 (AIDS) diagnosis within 12 months of HIV diagnosis. 2. Stage 3 (AIDS): includes persons diagnosed with stage 3 in 2020, regardless of year of HIV diagnosis. 3. Includes sex with male and probable heterosexual transmission as noted in medical chart. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding. 2020 Georgia HIV Surveillance Summary Page 14 Table 5. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), Georgia, as of 12/31/2020 Total Gender Identity Cisgender Male Cisgender Female Transgender Persons Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Current Age Group (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact2 Adult Other3 Perinatal/other pediatric4 Unknown Transmission Category (Adjusted)5 Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact2 Adult Other3 Perinatal/other pediatric4 PLWH N 59,949 %* 100.0 45,156 75.2 14,110 23.5 683 1.1 40,999 68.2 10,462 17.4 4,516 7.5 28 0.0 320 0.5 2,785 4.6 81 0.1 302 0.5 6,710 11.2 14,088 23.5 12,627 21.0 15,792 26.3 10,461 17.4 30,440 50.7 2,294 3.8 1,877 3.1 10,058 16.7 569 0.9 73 0.1 14,762 24.6 37,044 61.7 3,360 5.6 2,314 3.9 15,739 26.2 569 0.9 73 0.1 Ever Stage 3 (AIDS)1 N %* 30,134 100.0 22,612 74.9 7,211 23.9 311 1.0 20,908 69.3 5,121 17.0 2,266 7.5 11 0.0 118 0.4 1,588 5.3 22 0.1 44 0.1 1,556 5.2 5,362 17.8 6,679 22.1 9,762 32.4 6,748 22.4 14,691 48.7 1,608 5.3 1,207 4.0 5,616 18.6 289 1.0 20 0.1 6,744 22.4 17,696 58.6 2,214 7.3 1,451 4.8 8,338 27.6 289 1.0 20 0.1 * Percentages may not add up to 100% due to rounding. 1. Persons whose infection was ever classified as stage 3 (AIDS). 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure current age > 13, hemophilia, blood transfusion. 4. Perinatal/other pediatric: cases<13 born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. 2020 Georgia HIV Surveillance Summary Page 15 Table 6. Persons living with HIV (PLWH), and PLWH ever stage 3 (AIDS), Cis-Gender Males, Georgia, as of 12/31/2020 Total Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Current Age Group (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact2 Adult Other3 Perinatal/other pediatric4 Unknown Transmission Category (Adjusted)5 Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact2 Adult Other3 Perinatal/other pediatric4 N 44,459 PLWH %* 100.0 29,545 65.4 8,910 19.7 3,616 8.0 24 0.1 239 0.5 2,125 4.7 39 0.1 203 0.5 5,579 12.4 11,290 25.0 8,885 19.7 11,714 25.9 7,439 16.5 29,800 66.0 1,271 2.8 1,848 4.1 2,719 6.0 273 0.6 34 0.1 9,211 20.4 36,389 80.6 1,728 3.8 2,284 5.1 3,763 8.3 273 0.6 34 0.1 Ever Stage 3 (AIDS)1 N %* 22,488 100.0 14,951 66.1 4,415 19.5 1,818 8.0 8 0.0 94 0.4 1,202 5.3 12 0.1 27 0.1 1,261 5.6 4,308 19.1 4,742 21.0 7,338 32.5 4,923 21.8 14,407 63.7 923 4.1 1,190 5.3 1,675 7.4 139 0.6 10 0.0 4,268 18.9 17,404 77.0 1,199 5.3 1,433 6.3 2,304 10.2 139 0.6 10 0.0 * Percentages may not add up to 100% due to rounding. 1. Persons whose infection was ever classified as stage 3 (AIDS). 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure current age > 13, hemophilia, blood transfusion. 4. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. 2020 Georgia HIV Surveillance Summary Page 16 Table 7. Persons living with HIV (PLWH), and PLWH ever stage 3 (AIDS), Cis-Gender Females, Georgia, as of 12/31/2020 Total Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Current Age Group (Years) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Injection drug use Heterosexual contact2 Adult Other3 Perinatal/other pediatric4 Unknown Transmission Category (Adjusted)5 Injection drug use Heterosexual contact2 Adult Other3 Perinatal/other pediatric4 PLWH N 13,892 %* 100.0 10,860 77.0 1,504 10.7 820 5.8 4 0.0 81 0.6 623 4.4 42 0.3 96 0.7 956 6.8 2,468 17.5 3,584 25.4 3,978 28.2 2,981 21.1 1,017 7.2 7,317 51.9 291 2.1 39 0.3 5,446 38.6 1,623 11.5 11,935 84.6 291 2.1 39 0.3 Ever Stage 3 (AIDS)1 N 7,182 %* 100.0 5,688 78.9 692 9.6 406 5.6 3 0.0 24 0.3 369 5.1 10 0.1 16 0.2 247 3.4 920 12.8 1,853 25.7 2,366 32.8 1,798 24.9 682 9.5 3,932 54.5 146 2.0 10 0.1 2,441 33.9 1,010 14.0 6,015 83.4 146 2.0 10 0.1 * Percentages may not add up to 100% due to rounding. 1. Persons whose infection was ever classified as stage 3 (AIDS). 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure current age > 13, hemophilia, blood transfusion. 4. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. 2020 Georgia HIV Surveillance Summary Page 17 Table 8. Persons living with HIV (PLWH), and PLWH ever stage 3 (AIDS), Transgender Persons, Georgia, as of 12/31/2020 Total Gender Identity Transgender Woman Transgender Man Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Current Age Group (Years) 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Sexual contact2 Injection drug use Sexual contact and injection drug use Adult Other3 Unknown Transmission Category (Adjusted)4 Sexual contact2 Injection drug use Sexual contact and injection drug use Adult Other3 PLWH N 683 653 30 538 39 73 0 0 33 2 163 298 126 72 22 634 3 27 4 26 647 5 28 4 %* 100.0 95.6 4.4 78.8 5.7 10.7 0.0 0.0 4.8 0.3 23.9 43.6 18.4 10.5 3.2 91.2 0.4 4.0 0.6 3.8 94.6 0.7 4.1 0.6 Ever Stage 3 (AIDS)1 N %* 311 100.0 298 95.8 13 4.2 244 78.5 13 4.2 39 12.5 0 0.0 0 0.0 15 4.8 1 0.3 45 14.5 126 40.5 73 23.5 49 15.8 17 5.5 280 90.1 1 0.3 16 5.1 3 1.0 11 3.5 290 93.2 2 0.6 16 5.3 3 1.0 * Percentages may not add up to 100% due to rounding. 1. Persons whose infection was ever classified as stage 3 (AIDS). 2. Includes sex with male and probable heterosexual transmission as noted in medical chart 3. Includes perinatal exposure current age > 13, hemophilia, blood transfusion.4. Adjusted for missing risk using multiple imputation methods. 2020 Georgia HIV Surveillance Summary Page 18 HIV Diagnoses and Persons Living with HIV by Public Health District Table 9. HIV Diagnoses and Persons Living with HIV, District 1-1 (Rome), Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing Total Gender Identity Cisgender Male HIV diagnoses N 53 %* 100.0 38 71.7 PLWH as of 12/31/2020 N %* 1,239 100.0 896 72.3 Cisgender Female 14 26.4 339 27.4 Transgender Woman <5 <5 Transgender Man 0 0.0 0 0.0 Race/Ethnicity Black/Non Hispanic 28 52.8 506 40.8 White/Non Hispanic 21 39.6 557 45.0 Hispanic/Latino, Any Race <5 104 8.4 American Indian/Alaska Native 0 0.0 0 0.0 Asian/Native Hawaiian/Pacific Islander 0 0.0 5 0.4 Multiple races 0 0.0 48 3.9 Age Group (at diagnosis for diagnosed, current for PLWH) <13 0 0.0 <5 -- 13-19 <5 -- 9 0.7 20-29 19 35.8 115 9.3 30-39 13 24.5 216 17.4 40-49 8 15.1 282 22.8 50-59 8 15.1 353 28.5 60+ <5 -- 263 21.2 Transmission Category (Unadjusted) Male-to-male sexual contact 23 43.4 515 41.6 Injection drug use <5 -- 92 7.4 Male-to-male sexual contact and injection drug use <5 Heterosexual contact1 12 Adult Other2 0 Perinatal/other pediatric3 0 -- 65 5.2 22.6 206 16.6 0.0 20 1.6 0.0 <5 -- Unknown Transmission Category (Adjusted)4 13 24.5 340 27.4 Male-to-male sexual contact 30 57.4 669 54.0 Injection drug use <5 -- 119 9.6 Male-to-male sexual contact and injection drug use <5 Heterosexual contact1 17 Adult Other2 0 Perinatal/other pediatric3 0 -- 78 6.3 32.5 333 26.9 0.0 20 1.6 0.0 <5 -- * Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2020 Georgia HIV Surveillance Summary Page 19 Table 10. HIV Diagnoses and Persons Living with HIV, District 1-2 (Dalton), Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing Total Gender Identity Cisgender Male Cisgender Female Transgender Woman Transgender Man Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group (at diagnosis for diagnosed, current for PLWH) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)3 Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric4 HIV diagnoses N %* 23 100.0 17 73.9 <5 -- <5 -- 0 0.0 <5 -- 15 65.2 5 21.7 0 0.0 0 0.0 0 0.0 0 0.0 <5 -- 8 34.8 9 39.1 <5 -- <5 -- 0 0.0 13 56.5 <5 -- <5 -- <5 -- 0 0.0 0 0.0 <5 -- 14 59.1 <5 -- <5 -- 5 22.2 0 0.0 0 0.0 PLWH as of 12/31/2020 N %* 722 100.0 566 78.4 147 20.4 5 0.7 0 0.0 136 18.8 407 56.4 127 17.6 0 0.0 <5 -- 35 4.8 0 0.0 <5 -- 72 10.0 122 16.9 175 24.2 202 28.0 148 20.5 366 50.7 33 4.6 48 6.6 100 13.9 <5 -- 0 0.0 171 23.7 447 62.0 46 6.3 54 7.5 156 21.6 <5 -- 0 0.0 * Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion. 3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation 202m0etGhoedos.rAgdiajusHteIdVsuSbutorvtaelsilmlaany cbeedSifufemrenmt farormy unadjusted subtotals due to rounding Page 20 Table 11. HIV Diagnoses and Persons Living with HIV, District 2 (Gainesville), Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing Total Gender Identity Cisgender Male Cisgender Female Transgender Woman Transgender Man Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group (at diagnosis for diagnosed, current for PLWH) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)4 Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 HIV diagnoses N %* 48 100.0 33 68.8 13 27.1 <5 -- 0 0.0 18 37.5 18 37.5 6 12.5 0 0.0 <5 -- <5 -- 0 0.0 <5 -- 20 41.7 9 18.8 <5 -- 8 16.7 <5 -- 24 50.0 <5 -- <5 -- 8 16.7 0 0.0 0 0.0 14 29.2 31 64.0 <5 -- <5 -- 13 27.5 0 0.0 0 0.0 PLWH as of 12/31/2020 N %* 963 100.0 679 70.5 273 28.3 9 0.9 0 0.0 240 24.9 471 48.9 150 15.6 <5 22 2.3 53 5.5 0 0.0 <5 0.4 97 10.1 173 18.0 224 23.3 286 29.7 179 18.6 404 42.0 41 4.3 49 5.1 158 16.4 9 0.9 0 0.0 302 31.4 534 55.5 64 6.7 58 6.0 272 28.3 9 0.9 0 0.0 * Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2020 Georgia HIV Surveillance Summary Page 21 Table 12. HIV Diagnoses and Persons Living with HIV, District 3-1 (Cobb/Douglas), Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing HIV diagnoses PLWH as of 12/31/2020 Total Gender Identity Cisgender Male Cisgender Female Transgender Woman Transgender Man Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races N %* N %* 160 100.0 4,311 100.0 126 78.8 3,296 76.5 29 18.1 957 22.2 5 3.1 49 1.1 0 0.0 <5 107 66.9 2,719 63.1 34 21.3 844 19.6 15 9.4 455 10.6 0 0.0 <5 -- <5 -- 17 0.4 <5 -- 224 5.2 Age Group (at diagnosis for diagnosed, current for PLWH) <13 0 0.0 5 0.1 13-19 5 3.1 12 0.3 20-29 69 43.1 539 12.5 30-39 56 35.0 1,134 26.3 40-49 19 11.9 961 22.3 50-59 7 4.4 1,064 24.7 60+ <5 -- 595 13.8 Transmission Category (Unadjusted) Male-to-male sexual contact 92 57.5 2,358 54.7 Injection drug use <5 -- 122 2.8 Male-to-male sexual contact and injection drug use <5 -- 122 2.8 Heterosexual contact1 26 16.3 750 17.4 Adult Other2 0 0.0 40 0.9 Perinatal/other pediatric3 0 0.0 5 0.1 Unknown 37 23.1 914 21.2 Transmission Category (Adjusted)4 Male-to-male sexual contact 113 70.4 2,820 65.4 Injection drug use 5 2.9 184 4.3 Male-to-male sexual contact and injection drug use <5 -- 150 3.5 Heterosexual contact1 39 24.3 1,060 24.6 Adult Other2 0 0.0 40 0.9 Perinatal/other pediatric3 0 0.0 5 0.1 * Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases<13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2020 Georgia HIV Surveillance Summary Page 22 Table 13. HIV Diagnoses and Persons Living with HIV, District 3-2 (Fulton), Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing HIV diagnoses PLWH as of 12/31/2020 N %* N %* Total Gender Identity Cisgender Male 481 100.0 16,377 404 84.0 13602 100.0 83.1 Cisgender Female 62 12.9 2520 15.4 Transgender Woman 15 3.1 211 1.3 Transgender Man 0 0.0 7 0.0 Race/Ethnicity Black/Non Hispanic 384 79.8 11901 72.7 White/Non Hispanic 55 11.4 2494 15.2 Hispanic/Latino, Any Race 28 5.8 960 5.9 American Indian/Alaska Native <5 -- 8 0.0 Asian/Native Hawaiian/Pacific Islander <5 -- 59 0.4 Multiple races 8 1.7 739 4.5 Age Group (at diagnosis for diagnosed, current for PLWH) <13 0 0.0 11 0.1 13-19 18 3.7 41 0.3 20-29 195 40.5 1679 10.3 30-39 148 30.8 4178 25.5 40-49 54 11.2 3449 21.1 50-59 48 10.0 4250 26.0 60+ 18 3.7 2763 16.9 Transmission Category (Unadjusted) Male-to-male sexual contact 324 67.4 10109 61.7 Injection drug use <5 -- 620 3.8 Male-to-male sexual contact and injection drug use 8 1.7 614 3.7 Heterosexual contact1 74 15.4 1910 11.7 Adult Other2 0 0.0 97 0.6 Perinatal/other pediatric3 0 0.0 7 0.0 Unknown 72 15.0 3020 18.4 Transmission Category (Adjusted)4 Male-to-male sexual contact 362 75.3 11703 71.5 Injection drug use 7 1.5 812 5.0 Male-to-male sexual contact and injection drug use 9 2.0 721 4.4 Heterosexual contact1 98 20.4 2818 17.2 Adult Other2 0 0.0 97 0.6 Perinatal/other pediatric3 0 0.0 7 0.0 * Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2020 Georgia HIV Surveillance Summary Page 23 Table 14. HIV Diagnoses and Persons Living with HIV, District 3-3 (Clayton), Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing Total Gender Identity Cisgender Male HIV diagnoses N %* 113 100.0 86 76.1 PLWH as of 12/31/2020 N %* 3,056 100.0 2,206 72.2 Cisgender Female 24 21.2 796 26.0 Transgender Woman <5 -- 49 1.6 Transgender Man 0 0.0 <5 -- Race/Ethnicity Black/Non Hispanic 97 85.8 2,537 83.0 White/Non Hispanic 6 5.3 117 3.8 Hispanic/Latino, Any Race 8 7.1 198 6.5 American Indian/Alaska Native 0 0.0 <5 -- Asian/Native Hawaiian/Pacific Islander 0 0.0 25 0.8 Multiple races <5 -- 146 4.8 Age Group (at diagnosis for diagnosed, current for PLWH) <13 0 0.0 6 0.2 13-19 <5 -- 14 0.5 20-29 55 48.7 481 15.7 30-39 31 27.4 826 27.0 40-49 13 11.5 639 20.9 50-59 10 8.9 695 22.7 60+ <5 -- 395 12.9 Transmission Category (Unadjusted) Male-to-male sexual contact 67 59.3 1,616 52.9 Injection drug use <5 -- 91 3.0 Male-to-male sexual contact and injection drug 0 0.0 70 2.3 use Heterosexual contact1 21 18.6 560 18.3 Adult Other2 0 0.0 35 1.1 Perinatal/other pediatric3 0 0.0 6 0.2 Unknown Transmission Category (Adjusted)4 Male-to-male sexual contact 24 21.2 678 22.2 79 70.0 1,904 62.3 Injection drug use <5 -- 135 4.4 Male-to-male sexual contact and injection drug <5 -- 87 2.9 use Heterosexual contact1 29 26.0 861 28.2 Adult Other2 0 0.0 35 1.1 Perinatal/other pediatric3 0 0.0 6 0.2 * Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2020 Georgia HIV Surveillance Summary Page 24 Table 15. HIV Diagnoses and Persons Living with HIV, District 3-4 (East Metro), Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing HIV diagnoses PLWH as of 12/31/2020 Total Gender Identity Cisgender Male N %* N %* 253 100 4,368 100 202 79.8 3,131 71.7 Cisgender Female 49 19.4 1,187 27.2 Transgender Woman <5 --0 39 0.9 Transgender Man 0 0.0 <5 -- Race/Ethnicity Black/Non Hispanic 152 60.1 2,658 60.9 White/Non Hispanic 28 11.1 705 16.1 Hispanic/Latino, Any Race 60 23.7 652 14.9 American Indian/Alaska Native 0 0.0 0 0.0 Asian/Native Hawaiian/Pacific Islander 5 2.0 68 1.6 Multiple races <5 -- 205 4.7 Age Group (at diagnosis for diagnosed, current for PLWH) <13 0 0.0 6 0.1 13-19 9 4.5 24 0.6 20-29 86 43.0 576 13.5 30-39 54 27.0 897 21.0 40-49 23 11.5 1,109 26.0 50-59 19 9.5 1,161 27.2 60+ 9 4.5 498 11.7 Transmission Category (Unadjusted) Male-to-male sexual contact 108 54.0 2,012 47.1 Injection drug use <5 -- 136 3.2 Male-to-male sexual contact and injection <5 -- 115 2.7 drug use Heterosexual contact1 22 11.0 765 17.9 Adult Other2 0 0.0 58 1.4 Perinatal/other pediatric3 0 0.0 6 0.1 Unknown 63 31.5 1,179 27.6 Transmission Category (Adjusted)4 Male-to-male sexual contact 133 66.7 2,527 59.2 Injection drug use 8 4.1 218 5.1 Male-to-male sexual contact and injection <5 -- 151 3.5 drug use Heterosexual contact1 53 26.4 1,236 28.9 Adult Other2 0 0.0 58 1.4 Perinatal/other pediatric3 0 0.0 6 0.1 * Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2020 Georgia HIV Surveillance Summary Page 25 Table 16. HIV Diagnoses and Persons Living with HIV, District 3-5 (DeKalb), Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing Total Gender Identity Cisgender Male Cisgender Female Transgender Woman Transgender Man Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group (at diagnosis for diagnosed, current for PLWH) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)4 Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 HIV diagnoses N %* 278 100.0 213 76.6 57 20.5 8 2.9 0 0.0 214 77.0 27 9.7 25 9.0 <5 -- <5 -- <5 -- <5 -- 10 3.6 113 40.6 75 27.0 38 13.7 35 12.6 6 2.2 163 58.6 6 2.2 5 1.8 36 13.0 0 0.0 0 0.0 68 24.5 189 67.9 10 3.6 6 2.1 69 24.6 0 0.0 0 0.0 PLWH as of 12/31/2020 N %* 9,974 100.0 7,942 79.6 1,880 18.8 127 1.3 5 0.1 7,103 71.2 1,546 15.5 701 7.0 <5 -- 76 0.8 433 4.3 14 0.1 43 0.4 1,011 10.1 2,429 24.4 2,155 21.6 2,650 26.6 1,671 16.8 5,900 59.2 246 2.5 299 3.0 1,368 13.7 74 0.7 12 0.1 2,075 20.8 6,913 69.3 392 3.9 371 3.7 2,099 21.0 74 0.7 12 0.1 * Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2020 Georgia HIV Surveillance Summary Page 26 Table 17. HIV Diagnoses and Persons Living with HIV, District 4 (LaGrange), Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing Total Gender Identity Cisgender Male Cisgender Female Transgender Woman Transgender Man Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group (at diagnosis for diagnosed, current for PLWH) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)4 Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 HIV diagnoses N %* 96 100.0 74 77.1 18 18.8 <5 -- 0 0.0 70 72.9 16 16.7 6 6.3 0 0.0 <5 -- <5 -- 0 0.0 5 5.2 40 41.7 24 25.0 15 15.6 5 5.2 7 7.3 52 54.2 0 0.0 0 0.0 21 21.9 0 0.0 0 0.0 23 24.0 68 70.4 <5 -- <5 -- 25 25.8 0 0.0 0 0.0 PLWH as of 12/31/2020 N %* 2,529 100.0 1,821 72.0 679 26.8 25 1.0 <5 -- 1,653 65.4 544 21.5 157 6.2 <5 -- 7 0.3 136 5.4 5 0.2 25 1.0 321 12.7 557 22.0 519 20.5 659 26.1 442 17.5 1,154 45.6 103 4.1 74 2.9 478 18.9 33 1.3 5 0.2 682 27.0 1,455 57.5 159 6.3 96 3.8 752 29.8 33 1.3 5 0.2 * Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2020 Georgia HIV Surveillance Summary Page 27 Table 18. HIV Diagnoses and Persons Living with HIV, District 5-1 (Dublin), Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing Total Gender Identity Cisgender Male HIV diagnoses N %* 16 100.0 13 81.3 PLWH as of 12/31/2020 N %* 608 100.0 409 67.3 Cisgender Female <5 -- 195 32.1 Transgender Woman <5 -- <5 -- Transgender Man 0 0.0 0 0.0 Race/Ethnicity Black/Non Hispanic 15 93.8 443 72.9 White/Non Hispanic <5 -- 77 12.7 Hispanic/Latino, Any Race 0 0.0 50 8.2 American Indian/Alaska Native 0 0.0 0 0.0 Asian/Native Hawaiian/Pacific Islander 0 0.0 0 0.0 Multiple races 0 0.0 32 5.3 Age Group (at diagnosis for diagnosed, current for PLWH) <13 0 0.0 <5 -- <5 <5 -- 20-29 7 43.8 43 7.1 30-39 <5 -- 100 16.4 40-49 <5 -- 138 22.7 50-59 <5 -- 188 30.9 60+ <5 -- 136 22.4 Transmission Category (Unadjusted) Male-to-male sexual contact 8 50.0 149 24.5 Injection drug use 0 0.0 47 7.7 Male-to-male sexual contact and injection drug use <5 -- 20 3.3 Heterosexual contact1 <5 -- 141 23.2 Adult Other2 0 0.0 <5 -- Perinatal/other pediatric3 0 0.0 <5 -- Unknown 5 31.3 246 40.5 Transmission Category (Adjusted)3 Male-to-male sexual contact 11 68.1 262 43.0 Injection drug use <5 -- 69 11.3 Male-to-male sexual contact and injection drug use <5 -- 28 4.6 Heterosexual contact1 <5 -- 239 39.3 Adult Other2 0 0.0 <5 -- Perinatal/other pediatric3 0 0.0 <5 -- * Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion. 3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2020 Georgia HIV Surveillance Summary Page 28 Table 19. HIV Diagnoses and Persons Living with HIV, District 5-2 (Macon), Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing Total Gender Identity Cisgender Male Cisgender Female Transgender Woman Transgender Man Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group (at diagnosis for diagnosed, current for PLWH) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)4 Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 HIV diagnoses N %* 83 100.0 58 69.9 25 30.1 0 0.0 0 0.0 65 78.3 14 16.9 <5 -- 0 0.0 0 0.0 <5 -- 0 0.0 0 0.0 32 38.6 29 34.9 13 15.7 7 8.4 <5 -- 34 41.0 <5 -- <5 -- 24 28.9 0 0.0 0 0.0 21 25.3 49 59.5 <5 -- <5 -- 28 34.2 0 0.0 0 0.0 PLWH as of 12/31/2020 N %* 2,332 100.0 1,587 68.1 720 30.9 19 0.8 0 0.0 1,748 75.0 343 14.7 99 4.2 <5 -- <5 -- 112 4.8 <5 -- 15 0.6 289 12.4 521 22.3 455 19.5 605 25.9 443 19.0 888 38.1 89 3.8 71 3.0 474 20.3 24 1.0 <5 -- 782 33.5 1,233 52.9 156 6.7 91 3.9 800 34.3 24 1.0 <5 -- * Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases<13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2020 Georgia HIV Surveillance Summary Page 29 Table 20. HIV Diagnoses and Persons Living with HIV, District 6 (Augusta), Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing Total Gender Identity Cisgender Male Cisgender Female Transgender Woman Transgender Man Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group (at diagnosis for diagnosed, current for PLWH) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)4 Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 HIV diagnoses N %* 73 100.0 49 67.1 19 26.0 5 6.8 0 0.0 58 79.5 12 16.4 <5 -- 0 0.0 0 0.0 0 0.0 0 0.0 5 6.8 32 43.8 21 28.8 7 9.6 7 9.6 <5 -- 37 50.7 <5 -- 0 0.0 18 24.7 0 0.0 0 0.0 17 23.3 47 63.8 <5 -- <5 -- 22 30.0 0 0.0 0 0.0 PLWH as of 12/31/2020 N %* 2,287 100.0 1,531 66.9 729 31.9 23 1.0 <5 -- 1,725 75.4 380 16.6 76 3.3 <5 -- 5 0.2 83 3.6 <5 -- 46 2.0 283 12.4 435 19.0 360 15.7 632 27.6 527 23.0 898 39.3 144 6.3 90 3.9 496 21.7 74 3.2 <5 -- 581 25.4 1,101 48.2 199 8.7 103 4.5 789 34.5 74 3.2 <5 -- * Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2020 Georgia HIV Surveillance Summary Page 30 Table 21. HIV Diagnoses and Persons Living with HIV, District 7 (Columbus), Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing Total Gender Identity Cisgender Male Cisgender Female Transgender Woman Transgender Man Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group (at diagnosis for diagnosed, current for PLWH) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)4 Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 HIV diagnoses N %* 87 100.0 58 66.7 28 32.2 <5 -- 0 0.0 70 80.5 17 19.5 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 5 5.7 25 28.7 25 28.7 16 18.4 11 12.6 5 5.7 32 36.8 <5 -- 0 0.0 30 34.5 0 0.0 0 0.0 22 25.3 43 49.2 5 5.2 <5 -- 39 44.9 0 0.0 0 0.0 PLWH as of 12/31/2020 N %* 1,918 100.0 1,264 65.9 636 33.2 12 0.6 0 0.0 1,417 73.9 244 12.7 110 5.7 <5 -- <5 -- 83 4.3 <5 -- 13 0.7 214 11.2 390 20.3 411 21.4 506 26.4 380 19.8 614 32.0 105 5.5 44 2.3 522 27.2 21 1.1 <5 -- 608 31.7 850 44.3 147 7.7 60 3.1 773 40.3 21 1.1 <5 -- * Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2020 Georgia HIV Surveillance Summary Page 31 Table 22. HIV Diagnoses and Persons Living with HIV, District 8-1 (Valdosta), Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing Total Gender Identity Cisgender Male Cisgender Female Transgender Woman Transgender Man Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group (at diagnosis for diagnosed, current for PLWH) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)4 Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 HIV diagnoses N %* 47 100.0 40 85.1 7 14.9 0 0.0 0 0.0 37 78.7 8 17.0 <5 -- 0 0.0 0 0.0 0 0.0 0 0.0 <5 -- 20 42.6 4 8.5 10 21.3 7 14.9 <5 -- 19 40.4 0 0.0 0 0.0 9 19.1 0 0.0 0 0.0 19 40.4 31 65.7 <5 -- 0 0.2 15 32.6 0 0.0 0 0.0 PLWH as of 12/31/2020 N %* 1,244 100.0 750 60.3 485 39.0 7 0.6 0 0.0 861 69.2 215 17.3 98 7.9 0 0.0 <5 -- 57 4.6 <5 -- <5 -- 131 10.5 229 18.4 266 21.4 357 28.7 256 20.6 356 28.6 53 4.3 32 2.6 464 37.3 7 0.6 <5 -- 330 26.5 483 38.8 78 6.3 39 3.1 625 50.3 7 0.6 <5 -- * Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2020 Georgia HIV Surveillance Summary Page 32 Table 23. HIV Diagnoses and Persons Living with HIV, District 8-2 (Albany), Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing Total Gender Identity Cisgender Male Cisgender Female Transgender Woman Transgender Man Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group (at diagnosis for diagnosed, current for PLWH) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)4 Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 HIV diagnoses N %* 77 100.0 44 57.1 32 41.6 <5 -- 0 0.0 64 83.1 12 15.6 <5 -- 0 0.0 0 0.0 0 0.0 0 0.0 11 14.3 27 35.1 14 18.2 11 14.3 10 13.0 <5 -- 30 39.0 <5 -- <5 -- 23 29.9 0 0.0 0 0.0 21 27.3 36 47.1 5 6.1 <5 -- 35 45.3 0 0.0 0 0.0 PLWH as of 12/31/2020 N %* 1,792 100.0 1104 61.6 673 37.6 11 0.6 <5 -- 1433 80.0 182 10.2 72 4.0 <5 -- <5 -- 90 5.0 <5 -- 18 1.0 225 12.6 362 20.2 372 20.8 449 25.1 362 20.2 610 34.0 73 4.1 42 2.3 432 24.1 23 1.3 <5 -- 609 34.0 807 45.0 123 6.9 53 3.0 771 43.0 23 1.3 <5 -- * Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2020 Georgia HIV Surveillance Summary Page 33 Table 24. HIV Diagnoses and Persons Living with HIV, District 9-1 (Savannah), Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing Total Gender Identity Cisgender Male Cisgender Female Transgender Woman Transgender Man Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group (at diagnosis for diagnosed, current for PLWH) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)4 Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 HIV diagnoses N %* 101 100.0 76 75.2 23 22.8 <5 -- 0 0.0 69 68.3 21 20.8 7 6.9 0 0.0 <5 -- 0 0.0 0 0.0 6 5.9 35 34.7 28 27.7 10 9.9 16 15.8 6 5.9 42 41.6 <5 -- <5 -- 16 15.8 0 0.0 0 0.0 39 38.6 60 58.9 6 6.1 <5 -- 31 30.4 0 0.0 0 0.0 PLWH as of 12/31/2020 N %* 2,823 100.0 1,894 67.1 896 31.7 22 0.8 <5 -- 1,865 66.1 579 20.5 192 6.8 <5 -- 11 0.4 139 4.9 8 0.3 16 0.6 318 11.3 615 21.8 483 17.1 772 27.3 610 21.6 1,057 37.4 153 5.4 65 2.3 551 19.5 34 1.2 7 0.2 956 33.9 1,427 50.6 229 8.1 90 3.2 998 35.4 34 1.2 7 0.2 * Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2020 Georgia HIV Surveillance Summary Page 34 Table 25. HIV Diagnoses and Persons Living with HIV, District 9-2 (Waycross), Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing Total Gender Identity Cisgender Male Cisgender Female Transgender Woman Transgender Man HIV diagnoses N %* 47 100.0 38 80.9 8 17.0 <5 -- 0 0.0 PLWH as of 12/31/2020 N %* 1,266 100.0 834 65.9 424 33.5 7 0.6 0 0.0 Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races 26 55.3 772 61.0 13 27.7 267 21.1 7 14.9 115 9.1 0 0.0 0 0.0 0 0.0 <5 -- <5 -- 84 6.6 Age Group (at diagnosis for diagnosed, current for PLWH) 0 0.0 0 0.0 13-19 <5 -- <5 -- 20-29 18 38.3 118 9.3 30-39 15 31.9 268 21.2 40-49 5 10.6 260 20.5 50-59 5 10.6 374 29.5 60+ <5 -- 242 19.1 Transmission Category (Unadjusted) Male-to-male sexual contact 18 38.3 410 32.4 Injection drug use <5 -- 65 5.1 Male-to-male sexual contact and injection drug use <5 -- 39 3.1 Heterosexual contact1 10 21.3 309 24.4 Adult Other2 0 0.0 12 0.9 Perinatal/other pediatric3 0 0.0 0 0.0 Unknown 16 34.0 431 34.0 Transmission Category (Adjusted)3 Male-to-male sexual contact 28 60.2 575 45.5 Injection drug use <5 -- 105 8.3 Male-to-male sexual contact and injection drug use <5 -- 50 3.9 Heterosexual contact1 15 30.9 498 39.4 Adult Other2 0 0.0 12 0.9 Perinatal/other pediatric3 0 0.0 0 0.0 * Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion. 3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2020 Georgia HIV Surveillance Summary Page 35 Table 26. HIV Diagnoses and Persons Living with HIV, District 10 (Athens), Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing Total Gender Identity Cisgender Male Cisgender Female Transgender Woman Transgender Man Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group (at diagnosis for diagnosed, current for PLWH) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)4 Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 HIV diagnoses N %* 42 100.0 30 71.4 10 23.8 <5 -- <5 -- 23 54.8 10 23.8 5 11.9 0 0.0 <5 -- <5 -- 0 0.0 <5 -- 17 40.5 10 23.8 <5 9.5 6 14.3 <5 9.5 23 54.8 <5 -- 0 0.0 10 23.8 0 0.0 0 0.0 7 16.7 25 59.0 <5 -- 0 0.0 13 31.0 0 0.0 0 0.0 PLWH as of 12/31/2020 N %* 1,101 100.0 742 67.4 339 30.8 17 1.5 <5 -- 610 55.4 326 29.6 91 8.3 0 0.0 7 0.6 56 5.1 <5 --- 8 0.7 126 11.4 258 23.4 227 20.6 262 23.8 217 19.7 448 40.7 62 5.6 34 3.1 225 20.4 13 1.2 <5 -- 316 28.7 584 53.0 86 7.8 42 3.8 362 32.9 13 1.2 <5 -- * Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases<13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2020 Georgia HIV Surveillance Summary Page 36 HIV Diagnoses and Persons Living with HIV, Atlanta MSA Table 27. HIV Diagnoses and Persons Living with HIV, Atlanta Metropolitan Statistical Area1, Georgia, 2020 Total Gender Identity Cisgender Male HIV diagnoses N 1,379 %* 100.0 1,094 79.3 PLWH as of 12/31/2020 N 42,257 %* 100.0 33,226 78.6 Cisgender Female 239 17.3 8,432 20.0 Transgender Woman 43 3.1 507 1.2 Transgender Man <5 -- 24 0.1 Race/Ethnicity Black/Non Hispanic 1,008 73.1 29,182 69.0 White/Non Hispanic 183 13.3 6,945 16.4 Hispanic/Latino, Any Race 142 10.3 3,342 7.9 American Indian/Alaska Native <5 20 0.0 Asian/Native Hawaiian/Pacific Islander 15 1.1 273 0.6 Multiple races 16 1.2 1,956 4.6 Age Group (at diagnosis for diagnosed, current for PLWH) <13 <5 -- 50 0.1 13-19 62 4.5 175 0.4 20-29 576 41.8 4,740 11.2 30-39 392 28.4 10,439 24.7 40-49 173 12.5 9,089 21.5 50-59 128 9.3 10,958 25.9 60+ 47 3.4 6,806 16.1 Transmission Category (Unadjusted) Male-to-male sexual contact 855 62.0 24,011 56.8 Injection drug use 15 1.1 1,375 3.3 Male-to-male sexual contact and injection 19 1.4 1,336 3.2 drug use Heterosexual contact2 213 15.4 6,127 14.5 Adult Other3 0 0.0 347 0.8 Perinatal/other pediatric4 0 0.0 44 0.1 Unknown 277 20.1 9,026 21.4 Transmission Category (Adjusted)5 Male-to-male sexual contact 988 71.7 28,396 67.2 Injection drug use 31 2.3 1,988 4.7 Male-to-male sexual contact and injection 24 1.7 1,631 3.9 drug use Heterosexual contact2 322 23.3 9,307 22.0 Adult Other3 0 0.0 347 0.8 Perinatal/other pediatric4 0 0.0 44 0.1 *Percents may not add up to 100 due to rounding 1.Barrow, Bartow, Butts, Carroll, Cherokee, Clayton, Cobb, Coweta, Dawson, DeKalb, Douglas, Fayette, Forsyth, Fulton, Gwinnett, Haralson, Heard, Henry, Jasper, Lamar, Meriwether, Morgan, Newton, Paulding, Pickens, Pike, Rockdale, Spalding, Walton 2.Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure age>13, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases <13 years born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding 2020 Georgia HIV Surveillance Summary Page 37 Late Diagnoses by Public Health District and Atlanta MSA Table 28. Late diagnoses by Public Health District and for Atlanta Metropolitan Statistical Area, Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing HIV Diagnoses Late HIV Diagnoses Stage 3 [AIDS] within 12 months N N row % District 1-1 Northwest (Rome) 1-2 North Georgia (Dalton) 2 North (Gainesville) 3-1 Cobb-Douglas 3-2 Fulton 3-3 Clayton (Jonesboro) 3-4 East Metro (Lawrenceville) 3-5 DeKalb 4 LaGrange 5-1 South Central (Dublin) 5-2 North Central (Macon) 6 East Central (Augusta) 7 West Central (Columbus) 8-1 South (Valdosta) 8-2 Southwest (Albany) 9-1 Coastal (Savannah) 9-2 Southeast (Waycross) 10 Northeast (Athens) Atlanta MSA1 53 23 48 160 481 113 185 278 96 16 83 73 87 47 77 101 47 42 1,379 17 32.1 5 21.7 12 25.0 42 26.3 92 19.1 21 18.6 43 23.2 60 21.6 16 16.7 4 25.0 19 22.9 18 24.7 26 29.9 14 29.8 22 28.6 28 27.7 10 21.3 10 23.8 298 21.6 1. Barrow, Bartow, Butts, Carroll, Cherokee, Clayton, Cobb, Coweta, Dawson, DeKalb, Douglas, Fayette, Forsyth, Fulton, Gwinnett, Haralson, Heard, Henry, Jasper, Lamar, Meriwether, Morgan, Newton, Paulding, Pickens, Pike, Rockdale, Spalding, Walton 2020 Georgia HIV Surveillance Summary Page 38 Public Health District and County Rates Table 29. HIV diagnoses and persons living with HIV (PLWH): Public Health District and County number and rates per 100,000 population, Georgia, 2020 Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing HIV Diagnoses (all stages) N1 1-1 Northwest (Rome) 53 Bartow County 8 Catoosa County <5 Chattooga County 0 Dade County <5 Floyd County 13 Gordon County <5 Haralson County <5 Paulding County 21 Polk County <5 Walker County <5 1-2 North Georgia (Dalton) 23 Cherokee County 12 Fannin County <5 Gilmer County <5 Murray County <5 Pickens County <5 Whitfield County <5 2 North (Gainesville) 48 Banks County 0 Dawson County <5 Forsyth County 14 Franklin County <5 Habersham County 5 Hart County 16 Hall County <5 Lumpkin County 0 Rabun County 0 Stephens County <5 Towns County <5 Union County <5 White County <5 3-1 Cobb/Douglas 160 Cobb County 137 Douglas County 23 3-2 Fulton 481 Fulton County 481 3-3 Clayton 113 Clayton County 113 3-4 East Metro (Lawrenceville) 185 Gwinnett County 150 Newton County 22 2020 Georgia HIV Surveillance Summary Rate/100,0002,3 7.7 7.3 -0.0 -13.2 --12.1 --4.6 4.5 -----6.4 0.0 -5.6 -10.9 7.7 -0.0 0.0 ----17.6 18.0 15.5 44.6 44.6 38.6 38.6 16.1 15.9 19.4 PLWH as of 12/31/2020 N1 1,239 233 72 53 15 245 74 35 370 66 76 722 403 36 60 36 40 147 963 13 31 228 45 75 350 48 37 20 49 9 33 25 4,311 3,619 692 16,377 16,377 3,056 3,056 4,532 3,672 417 Rate/100,0002,3 178.9 212.9 105.9 213.3 93.4 248.5 125.9 115.2 213.4 154.1 108.4 144.2 151.9 135.7 187.6 89.9 120.7 141.6 129.1 67.2 114.3 90.9 191.5 162.9 169.4 181.8 108.2 115.8 187.7 73.5 130.1 80.4 473.3 474.3 467.6 1520.0 1520.0 1044.3 1044.3 395.2 389.5 368.1 Page 39 Rockdale County 3-5 DeKalb 13 14.3 278 36.5 DeKalb County 4 LaGrange 278 36.5 96 10.8 Butts County 10 39.3 Carroll County 8 6.6 Coweta County 13 8.6 Fayette County 8 6.9 Heard County 0 0.0 Henry County 39 16.3 Lamar County <5 -- Meriwether County <5 -- Pike County 0 0.0 Spalding County 6 8.9 Troup County 7 10.0 Upson County <5 3.8 5-1 South Central (Dublin) 16 10.7 Bleckley County <5 -- Dodge County <5 -- Johnson County <5 -- Laurens County 8 16.8 Montgomery County 0 0.0 Pulaski County 0 0.0 Telfair County 0 0.0 Treutlen County <5 -- Wheeler County 0 0.0 Wilcox County <5 -- 5-2 North Central (Macon) 83 15.4 Baldwin County <5 -- Bibb County 42 27.5 Crawford County <5 -- Hancock County <5 -- Houston County 21 13.1 Jasper County <5 -- Jones County <5 -- Monroe County <5 -- Peach County 5 17.9 Putnam County <5 -- Twiggs County 0 0.0 Washington County <5 -- Wilkinson County 0 0.0 6 East Central (Augusta) 73 14.8 Burke County 5 22.1 Columbia County 8 5.0 Emanuel County 0 0.0 Glascock County 0 0.0 Jefferson County 5 32.8 Jenkins County 0 0.0 Lincoln County <5 -- McDuffie County <5 -- Richmond County 50 24.7 Screven County <5 -- Taliaferro County 0 0.0 Warren County <5 -- Wilkes County 0 0.0 7 West Central (Columbus) 87 23.6 Chattahoochee County 0 0.0 2020 Georgia HIV Surveillance Summary 443 9,974 9,974 2,529 116 254 285 229 14 1,005 47 75 13 227 196 68 608 48 80 32 197 15 25 88 23 31 69 2,332 164 1,249 23 45 456 23 48 57 127 36 23 60 21 2,287 101 236 61 7 57 34 18 63 1,611 46 9 20 24 1,918 13 487.1 1308.9 1308.9 284.6 456.2 208.8 188.9 197.7 116.9 420.3 244.0 354.4 68.0 336.7 279.1 256.3 406.3 370.5 391.2 331.0 414.6 166.4 223.4 557.6 337.1 399.9 811.6 433.8 363.6 817.7 188.0 529.8 284.8 158.8 166.7 203.3 454.4 159.9 283.8 297.8 238.3 462.7 446.0 147.2 271.0 234.6 373.4 388.7 224.1 297.7 797.2 328.3 576.2 382.3 247.6 519.4 123.2 Page 40 Clay County 0 0.0 Crisp County 7 31.8 Dooly County <5 -- Harris County <5 -- Macon County <5 -- Marion County 0 0.0 Muscogee County 68 34.6 Quitman County 0 0.0 Randolph County <5 -- Schley County 0 0.0 Stewart County4 0 0.0 Sumter County <5 -- Talbot County 0 0.0 Taylor County 0 0.0 Webster County 8-1 South (Valdosta) 0 0.0 47 18.1 Ben Hill County <5 -- Berrien County 0 0.0 Brooks County <5 -- Cook County 5 28.9 Echols County <5 -- Irwin County <5 -- Lanier County <5 -- Lowndes County 27 22.8 Tift County 8 19.6 Turner County <5 -- 8-2 Southwest (Albany) 77 22.6 Baker County 0 0.0 Calhoun County 0 0.0 Colquitt County 11 24.2 Decatur County 6 22.7 Dougherty County 38 43.9 Early County 0 0.0 Grady County <5 -- Lee County <5 -- Miller County 0 0.0 Mitchell County 5 23.1 Seminole County <5 -- Terrell County 0 0.0 Thomas County 7 15.8 Worth County <5 -- 9-1 Coastal (Savannah) 101 15.9 Bryan County <5 -- Camden County 0 0.0 Chatham County 63 21.8 Effingham County 6 9.1 Glynn County 18 21.0 Liberty County 12 19.0 Long County 0 0.0 McIntosh County 0 0.0 9-2 Southeast (Waycross) 47 12.5 Appling County <5 -- Atkinson County <5 -- Bacon County <5 -- Brantley County 0 0.0 Bulloch County 14 17.3 Candler County 0 0.0 2020 Georgia HIV Surveillance Summary 13 141 65 44 72 14 1,176 5 42 6 123 142 27 32 3 1,244 58 39 63 76 15 86 25 663 171 48 1,792 7 34 210 136 791 26 69 73 20 108 25 44 172 77 2,823 56 99 1,880 93 358 255 24 58 1,266 39 21 43 21 278 34 453.6 639.9 493.4 122.0 566.4 164.4 598.6 220.2 628.6 115.5 1838.8 484.9 439.5 396.3 115.6 479.1 349.1 200.9 410.2 439.5 374.8 916.2 232.8 560.6 420.0 609.0 526.1 235.6 545.7 461.1 514.0 914.7 259.0 281.7 241.5 355.7 500.0 310.2 516.3 387.6 385.5 444.9 137.4 178.7 649.5 141.4 418.4 404.7 119.0 403.1 337.1 212.8 250.2 389.6 109.4 343.9 309.5 Page 41 Charlton County <5 -- Clinch County 0 0.0 Coffee County 6 13.9 Evans County <5 -- Jeff Davis County 0 0.0 Pierce County <5 -- Tattnall County <5 -- Toombs County <5 -- Ware County 6 16.7 Wayne County <5 -- 10 Northeast (Athens) 42 7.9 Barrow County 6 7.0 Clarke County 23 18.0 Elbert County <5 -- Greene County <5 -- Jackson County 0 0.0 Madison County <5 -- Morgan County <5 -- Oconee County <5 -- Oglethorpe County <5 -- Walton County <5 -- 74 27 124 47 31 30 102 97 183 115 1,101 141 459 40 30 88 37 36 29 30 211 551.0 410.2 286.9 441.8 203.8 153.7 402.1 359.6 510.8 383.0 207.3 164.7 359.2 206.9 159.3 115.5 121.5 183.3 70.5 195.0 217.8 1. Values of 1-4 are censored 2. Rates are not calculated when numerator is <12. 3. Persons residing in correctional facilities are included in this report and may inflate rates in certain geographic regions where there are large numbers of HIV-positive inmates. 4. Most cases associated with a federal immigration detention facility located in this county. 2020 Georgia HIV Surveillance Summary Page 42 Distribution of General Population by Race/Ethnicity Table 30. Distribution of the general population by race/ethnicity, Georgia 2020 Race/Ethnicity White, Non-Hispanic Black, Non-Hispanic Hispanic/Latino, Any Race Asian, Non-Hispanic American Indian /Alaskan Native, Non-Hispanic Native Hawaiian/Pacific Islander, Non-Hispanic Total Number (%) 5,522,339 3,406,103 1,067,941 471,825 24,535 7,564 10,710,017 Source: Georgia Online Analytical Statistical Information System (https://oasis.state.ga.us/oasis/webquery/qryPopulation.aspx) 2020 Georgia HIV Surveillance Summary Page 43 HIV/AIDS RESOURCES: Georgia Department of Public Health http://dph.georgia.gov/what-hiv-and-aids Centers for Disease Control and Prevention http://www.cdc.gov/hiv/ AIDSVu http://aidsvu.org/ Reporting All health care providers diagnosing and/or providing care to a patient with HIV are required by Georgia law (O.C.G.A. 31-12-1) to report HIV infection using the HIV/AIDS Case Report Form. Case report forms should be completed within seven (7) days of diagnosing a patient with HIV and/or AIDS or within seven (7) days of assuming care of an HIV positive patient who is new to the provider, regardless of whether the patient has previously received care elsewhere. Adult and Pediatric case report forms are available at https://dph.georgia.gov/hivaids-case-reporting For more questions on HIV case reporting in Georgia please contact the HIV Surveillance Coordinator at 1800-827-9769 2020 Georgia HIV Surveillance Summary Page 44